Vu Tran

Mr. Vu Tran

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
VTVu Tran
Vu Tran
MJMonika Janda
Monika Janda
RLRobyn Lucas
Robyn Lucas
DMDonald S. A. McLeod
Donald S. A. McLeod
BTBridie S. Thompson
Bridie S. Thompson
RNRachel Neale
Rachel Neale
Sun exposure carries both harms and benefits. Exposing the skin to the sun is the main modifiable cause of skin cancers, which exert a considerable health and economic burden in Australia. The most well-established benefit of exposure to ultraviolet (UV) radiation is vitamin D production. Australia has the highest incidence of skin cancer in the world but, despite the high ambient UV radiation, approximately one quarter of the population is estimated to be vitamin D deficient. Balancing the risks and benefits is challenging and requires effective communication. We sought to provide a snapshot of public knowledge and attitudes regarding sun exposure and vitamin D and to examine the associations between these factors and sun protective behaviors. In 2020 we administered an online survey; 4824 participants with self-reported fair or medium skin color were included in this analysis. Only 25% and 34% of participants were able to identify the amount of time outdoors needed to maintain adequate vitamin D status in summer and winter, respectively and 25% were concerned that sunscreen use inhibits vitamin D synthesis. This lack of knowledge was associated with suboptimal sun protection practices. Public education is warranted to prevent over-exposure, while supporting natural vitamin D production.

10 September 2025 in British Journal of Dermatology
Verified
Journal Article
Closed access
VTVu Tran
Vu Tran
BRBriony L Duarte Romero
Briony L Duarte Romero
HAHayley Andersen
Hayley Andersen
MCMichael Clarke
Michael Clarke
Louisa GordonLouisa Gordon
Louisa Gordon
RNRachel Neale
Rachel Neale
Background: Sunscreen reduces vitamin D production in experimental studies. It is uncertain whether this translates to real-world settings. Objectives: To determine if routinely applying high sun protection factor (SPF) sunscreen for a year reduces serum 25-hydroxyvitamin D [25(OH)D] concentration. Methods: We conducted a population-based open-label randomized controlled trial in Australian participants aged 18–70 years who were not routinely using sunscreen or taking vitamin D supplements. Participants were randomized (1 : 1) using stratified, computer-generated permuted block randomization to routine application of SPF 50+ sunscreen on days the ultraviolet (UV) index was forecast to reach ≥ 3 (intervention) or discretionary sunscreen use (control), for approximately 1 year. We measured 25(OH)D concentration at baseline (winter/spring 2022) and at the end of summer and winter 2023; participants with no postbaseline concentrations (n = 11) were excluded from analyses. The primary outcome was change in 25(OH)D concentration from baseline. Vitamin D deficiency [25(OH)D concentration < 50 nmol L–1] in the final sample was an exploratory outcome. We analysed data using mixed-effects models and Poisson regression. We stratified our analysis by baseline 25(OH)D concentration, residential UV radiation (UVR) zone, skin exposure (derived from time outdoors and clothing use) and personal UVR exposure (derived by combining UVR zone and skin exposure). Sample and data analysis were performed blind to randomization group. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12621001752853). Results: Between 30 June and 29 November 2022, we randomized 639 participants (intervention, n = 319; control, n = 320). In total, 628 participants were analysed [intervention, n = 312; control, n = 316; median age 52 years (interquartile range 40–64)]. Altogether, 415 (66.1%) identified as female, 210 (33.4%) as male and 3 (0.5%) used another term. Mean (SD) baseline 25(OH)D concentration was balanced [intervention 63.5 (21.9) nmol L–1; control 62.1 (22.8) nmol L–1]. Adjusted mean differences from baseline were 1.6 nmol L–1 (intervention) and 6.8 nmol L–1 (control) [between-group treatment effect –5.2 nmol L–1, 95% confidence interval (CI) –7.2 to –3.2]. Treatment effects were consistent across almost all subgroups. Vitamin D deficiency (final sample) was higher in the intervention (n = 139/304; 45.7%) than in the control group (n = 115/312; 36.9%) (prevalence ratio 1.33, 95% CI 1.14–1.55). Conclusions: Routinely applying high SPF sunscreen results in lower 25(OH)D concentrations than would be seen with discretionary sunscreen use. Regular sunscreen users may need vitamin D supplementation.

4 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
VTVu Tran
Vu Tran
DMDonald S. A. McLeod
Donald S. A. McLeod
COCatherine M Olsen
Catherine M Olsen
NPNirmala Pandeya
Nirmala Pandeya
MWMary Waterhouse
Mary Waterhouse
RNRachel Neale
Rachel Neale
Background/Objectives: Vitamin D testing has increased significantly in developed countries in recent decades. We aimed to describe trends in vitamin D testing rates and factors associated with testing and vitamin D deficiency in Queensland, Australia (2011–2019). Methods: We used data from the QSkin Sun and Health Study (n = 40,417), a prospective population-based cohort study with linkage to the Medicare Benefits Schedule, Pharmaceutical Benefits Scheme, and pathology laboratories. Main outcomes included age-standardized incidence rate of vitamin D testing; having ≥1 vitamin D test during follow-up; vitamin D deficiency (25-hydroxyvitamin D concentration <50 nmol/L) in the first vitamin D test; and repeat vitamin D tests. Results: The age-standardized incidence rate of testing increased by 2% per quarter during follow-up. Of the 35,250 participants analyzed for associations with testing (median age of 57 years, 52% female), 45% had ≥1 vitamin D test. Among those tested, 56% had no apparent clinical indication for their initial vitamin D test, 21% were vitamin D deficient in their initial test, and 58% had a repeat test. Repeat testing occurred in 56% who were not deficient in their prior test, while only two-thirds of those deficient received a follow-up assessment. Participants who visited a general practitioner ≥2 times in the year prior to follow-up were 60% more likely to have ≥1 vitamin D test compared with those with no visit, but general practitioner (GP) visits were not associated with risk of vitamin D deficiency. Conclusions: These results suggest that initiatives are needed to help clinicians target vitamin D testing in alignment with clinical guidelines.


13 November 2026 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
VTVu Tran
Vu Tran
BRBriony L Duarte Romero
Briony L Duarte Romero
MCMichael Clarke
Michael Clarke
GHGunter Hartel
Gunter Hartel
DMDonald S A McLeod
Donald S A McLeod
RNRachel Neale
Rachel Neale
Context: Australian guidelines recommend an end-of-summer concentration of at least 60 nmol/L to avoid winter vitamin D deficiency. Objective: To estimate (1) the risk of end-of-winter vitamin D deficiency (25-hydroxyvitamin D concentration [25(OH)D] < 50 nmol/L) according to end-of-summer 25(OH)D concentrations and (2) the required 25(OH)D concentration at the end of summer to avoid vitamin D deficiency through winter across Australian regions. Design: Prospective population-based cohort study, nested within a randomized controlled trial (the Sun-D Trial). Setting: We recruited residents of Australia's eastern states via the Australian electoral roll, media, and email lists. Participants: Sun-D Trial control group participants who did not use vitamin D supplements (N = 251). Main Outcome Measures: Vitamin D deficiency at end of winter. Results: The overall prevalence of vitamin D deficiency at the end of winter was 41%. In those whose end-of-summer 25(OH)D concentration was ≥60 nmol/L, it was 31%. In the absence of vitamin D supplementation, end-of-summer 25(OH)D concentrations of 84 to 98 nmol/L, depending on location, are required to ensure a 90% probability of maintaining vitamin D adequacy through winter. Only 8% of participants in Victoria and Tasmania and less than half in other jurisdictions met these targets. Conclusion: Higher end-of-summer 25(OH)D concentrations than currently recommended are required to avoid vitamin D deficiency in winter in Australia. Clinicians might consider recommending vitamin D supplementation during winter for patients who do not meet end-of-summer targets, as this is likely the most practical option for mitigating the risk of winter deficiency, particularly for people living at higher latitudes.